Full Results of Tradjenta®’s CARMELINA® Cardiovascular Outcome Trial Presented by Boehringer Ingelheim and LillyAllbiopro2018-10-10T09:05:33+09:0010월 10th, 2018|
Novartis to Launch Innovation Labs Across the Globe, Including Silicon ValleyAllbiopro2018-10-10T09:04:36+09:0010월 10th, 2018|
Landmark Study: Researchers Cure Lethal Disease in Prenatal Mice Using CRISPRAllbiopro2018-10-10T09:01:56+09:0010월 10th, 2018|
Patient Death and Life-Threatening Side Effects Cause Affimed to Hold Phase I Cancer TrialsAllbiopro2018-10-10T09:01:00+09:0010월 10th, 2018|
Merck’s Frazier Joins Growing List of Pharma CEOs Attacking Drug RebatesAllbiopro2018-10-10T09:00:04+09:0010월 10th, 2018|
Nobel Prizes Underscore Benefits of Research, but Also Highlight ‘Worst Instincts’ of Industry: ReportAllbiopro2018-10-10T08:58:17+09:0010월 10th, 2018|
Gene Therapy Company MeiraGTx Buys Vector Neurosciences for Its Phase II Parkinson’s ProductAllbiopro2018-10-10T08:57:21+09:0010월 10th, 2018|
Summary or Objective Statement on Your Resume: Which Is Best?Allbiopro2018-10-10T08:56:24+09:0010월 10th, 2018|
Pfizer poaches Quest executive to spearhead digital, but the rest of Bourla’s supporting cast looks familiarAllbiopro2018-10-10T08:55:29+09:0010월 10th, 2018|
FDA reviewers endorse Celltrion’s Rituxan biosimilar ahead of panel voteAllbiopro2018-10-10T08:54:32+09:0010월 10th, 2018|
Stada, eyeing OTC expansion, circles Bristol-Myers’ French Upsa business: reportAllbiopro2018-10-10T08:53:39+09:0010월 10th, 2018|
Celgene notches positive Otezla data in scalp psoriasis as it guns for market expansionAllbiopro2018-10-10T08:53:13+09:0010월 10th, 2018|
Litigation teaches Chinese valsartan maker the downside of U.S. marketAllbiopro2018-10-10T08:52:46+09:0010월 10th, 2018|
Glympse Bio premieres with $22M series A and plan for in-body disease biosensorsAllbiopro2018-10-10T08:52:19+09:0010월 10th, 2018|
Rare disease startup Therachon to absorb GLyPharma and its SBS candidateAllbiopro2018-10-10T08:51:52+09:0010월 10th, 2018|
